Results overview. 2015 was a challenging year for Deltex with good sales growth generated in the US and other international markets (up £0.53m) and additional sales from third party products (up £0.32m) but this was offset by reduced sales to the NHS (down £0.95m), leaving overall sales down slightly at £6.41m (2014: £6.51m).
13 Apr 2016
Finals – Strong export markets offset by UK weakness
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Finals – Strong export markets offset by UK weakness
Deltex Medical Group plc (DEMG:LON) | 0.1 0 4.9% | Mkt Cap: 2.04m
- Published:
13 Apr 2016 -
Author:
Chris Thomas -
Pages:
4
Results overview. 2015 was a challenging year for Deltex with good sales growth generated in the US and other international markets (up £0.53m) and additional sales from third party products (up £0.32m) but this was offset by reduced sales to the NHS (down £0.95m), leaving overall sales down slightly at £6.41m (2014: £6.51m).